Sanders Capital LLC Buys 352,710 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Sanders Capital LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 6.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,757,410 shares of the healthcare conglomerate’s stock after purchasing an additional 352,710 shares during the period. UnitedHealth Group makes up about 6.1% of Sanders Capital LLC’s holdings, making the stock its 6th largest holding. Sanders Capital LLC owned about 0.62% of UnitedHealth Group worth $2,902,829,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of UNH. Moneta Group Investment Advisors LLC increased its holdings in UnitedHealth Group by 100,076.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after buying an additional 11,812,017 shares during the last quarter. Norges Bank purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $5,210,004,000. Osaic Holdings Inc. grew its holdings in shares of UnitedHealth Group by 776.9% during the second quarter. Osaic Holdings Inc. now owns 3,248,409 shares of the healthcare conglomerate’s stock worth $177,941,000 after purchasing an additional 2,877,983 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its holdings in shares of UnitedHealth Group by 1,682.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after purchasing an additional 2,540,538 shares during the last quarter. Finally, Bank of Montreal Can purchased a new position in shares of UnitedHealth Group during the second quarter worth about $1,087,367,000. Hedge funds and other institutional investors own 85.69% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Morgan Stanley dropped their price objective on UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating on the stock in a report on Monday, October 23rd. Stephens reiterated an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday. Jefferies Financial Group decreased their target price on shares of UnitedHealth Group from $565.00 to $503.00 and set a “hold” rating for the company in a research note on Monday, November 20th. Truist Financial reiterated a “buy” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Thursday, November 30th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 19th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $575.79.

Get Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Price Performance

UnitedHealth Group stock traded down $1.87 during mid-day trading on Friday, reaching $518.22. The company had a trading volume of 2,715,493 shares, compared to its average volume of 4,824,929. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $554.70. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.80. The company has a market capitalization of $479.31 billion, a P/E ratio of 21.74, a P/E/G ratio of 1.41 and a beta of 0.54. The stock’s 50-day simple moving average is $525.36 and its 200-day simple moving average is $517.77.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. During the same period last year, the company posted $5.34 EPS. The company’s revenue was up 14.1% on a year-over-year basis. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.84 EPS for the current year.

Insider Transactions at UnitedHealth Group

In other news, Director Stephen J. Hemsley sold 66,081 shares of the firm’s stock in a transaction that occurred on Tuesday, December 5th. The shares were sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the completion of the transaction, the director now directly owns 635,528 shares of the company’s stock, valued at approximately $349,788,255.92. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.